Last updated: 2026-10-13 07:45:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Pulsenmore Ltd. (PLSM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1,84, with a market capitalisation of $12,03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,75 to $12,97. This page covers its latest market performance, valuation, price trends and company information.
$12,03M | |
$1,94 | |
$12,97 | |
$1,75 | |
$1,85 | |
17,19K | |
73,39K | |
-- | |
$12,97 | |
$1,75 | |
-- | |
-- |
Pulsenmore Ltd. (PLSM) last closed at $1,85 as of 2026-10-12 21:40:00, unchanged from the previous close of $1,85.
During the latest regular trading session, PLSM traded between $1,75 and $12,97, with a volume of 17,19K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Pulsenmore Ltd. (PLSM) moved from $2,19 to $1,84, representing a decline of 16,21% ($0,36).
The stock traded between $1,75 and $2,28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 33,34 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,8%
PLSM is currently trading at $1,84, placing it 0,8% of the way from its 52-week low of $1,75 to its 52-week high of $12,97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
| Employees | 63 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pulsenmore Ltd. (PLSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.